Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2025-12-26 @ 2:11 AM
Study NCT ID:
NCT00881205
Status:
TERMINATED
Last Update Posted:
2012-03-12
First Post:
2009-04-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-04
Start Date Type:
None
Primary Completion Date:
2011-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-14
First Submit QC Date:
None
Study First Post Date:
2009-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-01-20
Results First Submit QC Date:
None
Results First Post Date:
2012-02-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-03-08
Last Update Post Date:
2012-03-12
Last Update Post Date Type:
ESTIMATED